HTTP/1.0 200 OK Content-Type: text/html
Pubdate: Sat, 14 Oct 2006 Source: National Post (Canada) Copyright: 2006 Southam Inc. Contact: http://www.nationalpost.com/ Details: http://www.mapinc.org/media/286 Bookmark: http://www.mapinc.org/mmjcn.htm (Cannabis - Medicinal - Canada) WHAT ARE THEY SMOKING? It may seem like nitpicking to single out a $4-million item amidst a $2-billion package of federal spending cuts, but the Harper government's proposed rollback of Health Canada funding for medical marijuana research is worth noting as another sign of deep (one might say chronic) conservative confusion over drug issues. Legalization advocates arguing the cannabis issue are often greeted by complaints from the anti-drug set, and from jittery physicians, that the medical benefits and hazards of marijuana are too poorly researched to permit widespread use. This is a remarkable claim in many different ways. Where, for instance, was this shining precautionary principle when Vioxx was being handed out like Halloween candy to patients at risk of cardiac complications? A PubMed search for "marijuana" reveals more than 10,000 published, peer-reviewed articles on the subject; surely some of these discuss the effects and risks of pot? The defenders of medical integrity who don't want to dole out reefers generally overlook the fact that its seekers are mostly those who have been served poorly by the scientific pharmacopoeia: cancer patients, nausea sufferers, multiple-sclerosis victims and those with nebulous, inexplicable neuralgic syndromes like fibromyalgia. But even setting this all aside, one is still left with an intractable question: How can a government ban a humane, cost-effective medical therapy on the grounds of insufficient research and then, with the other hand, suppress that same research in good conscience? Or, in other words: What kind of risk is worth forbidding but not worth quantifying? - --- MAP posted-by: Derek